Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation

• Sarmad Al-Marsoummi,
• Emilie Vomhof-DeKrey,
• Marc D. Basson

Affiliations

Sarmad Al-Marsoummi

Department of Biomedical Sciences, University of North Dakota School of Medicine and the Health Sciences, Grand Forks, ND, USA

Emilie Vomhof-DeKrey

Department of Biomedical Sciences, University of North Dakota School of Medicine and the Health Sciences, Grand Forks, ND, USA; Department of Surgery, University of North Dakota School of Medicine and the Health Sciences, Grand Forks, ND, USA

Marc D. Basson

Department of Biomedical Sciences, University of North Dakota School of Medicine and the Health Sciences, Grand Forks, ND, USA; Department of Surgery, University of North Dakota School of Medicine and the Health Sciences, Grand Forks, ND, USA; Department of Pathology, University of North Dakota School of Medicine and the Health Sciences, Grand Forks, ND, USA